Logo image of BRKR

BRUKER CORP (BRKR) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BRKR - US1167941087 - Common Stock

49.205 USD
+1.64 (+3.46%)
Last: 11/25/2025, 11:14:08 AM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BRKR. BRKR was compared to 58 industry peers in the Life Sciences Tools & Services industry. There are concerns on the financial health of BRKR while its profitability can be described as average. While showing a medium growth rate, BRKR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BRKR had positive earnings in the past year.
BRKR had a positive operating cash flow in the past year.
In the past 5 years BRKR has always been profitable.
Each year in the past 5 years BRKR had a positive operating cash flow.
BRKR Yearly Net Income VS EBIT VS OCF VS FCFBRKR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

BRKR has a better Return On Assets (-0.37%) than 65.52% of its industry peers.
With a decent Return On Equity value of -0.97%, BRKR is doing good in the industry, outperforming 65.52% of the companies in the same industry.
BRKR has a better Return On Invested Capital (4.01%) than 68.97% of its industry peers.
BRKR had an Average Return On Invested Capital over the past 3 years of 9.30%. This is below the industry average of 13.53%.
The 3 year average ROIC (9.30%) for BRKR is well above the current ROIC(4.01%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.37%
ROE -0.97%
ROIC 4.01%
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
BRKR Yearly ROA, ROE, ROICBRKR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

BRKR's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 8.99%, BRKR is in the better half of the industry, outperforming 65.52% of the companies in the same industry.
In the last couple of years the Operating Margin of BRKR has declined.
BRKR's Gross Margin of 48.00% is in line compared to the rest of the industry. BRKR outperforms 51.72% of its industry peers.
In the last couple of years the Gross Margin of BRKR has remained more or less at the same level.
Industry RankSector Rank
OM 8.99%
PM (TTM) N/A
GM 48%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
BRKR Yearly Profit, Operating, Gross MarginsBRKR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

2

2. Health

2.1 Basic Checks

BRKR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
BRKR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BRKR has less shares outstanding
Compared to 1 year ago, BRKR has a worse debt to assets ratio.
BRKR Yearly Shares OutstandingBRKR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
BRKR Yearly Total Debt VS Total AssetsBRKR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 2.49 indicates that BRKR is not a great score, but indicates only limited risk for bankruptcy at the moment.
BRKR has a Altman-Z score (2.49) which is in line with its industry peers.
BRKR has a Debt/Equity ratio of 0.82. This is a neutral value indicating BRKR is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.82, BRKR is not doing good in the industry: 74.14% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF N/A
Altman-Z 2.49
ROIC/WACC0.43
WACC9.33%
BRKR Yearly LT Debt VS Equity VS FCFBRKR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

BRKR has a Current Ratio of 1.85. This is a normal value and indicates that BRKR is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.85, BRKR is not doing good in the industry: 62.07% of the companies in the same industry are doing better.
BRKR has a Quick Ratio of 1.85. This is a bad value and indicates that BRKR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BRKR (0.89) is worse than 87.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 0.89
BRKR Yearly Current Assets VS Current LiabilitesBRKR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

BRKR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.37%.
The Earnings Per Share has been growing by 8.95% on average over the past years. This is quite good.
The Revenue has been growing slightly by 6.10% in the past year.
The Revenue has been growing by 10.19% on average over the past years. This is quite good.
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%

3.2 Future

The Earnings Per Share is expected to grow by 4.89% on average over the next years.
BRKR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.65% yearly.
EPS Next Y-17.24%
EPS Next 2Y-2.13%
EPS Next 3Y4.74%
EPS Next 5Y4.89%
Revenue Next Year2.6%
Revenue Next 2Y1.97%
Revenue Next 3Y3.23%
Revenue Next 5Y2.65%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BRKR Yearly Revenue VS EstimatesBRKR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B
BRKR Yearly EPS VS EstimatesBRKR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 24.60, the valuation of BRKR can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of BRKR indicates a rather cheap valuation: BRKR is cheaper than 81.03% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 25.65. BRKR is around the same levels.
With a Price/Forward Earnings ratio of 21.31, BRKR is valued on the expensive side.
Based on the Price/Forward Earnings ratio, BRKR is valued cheaper than 84.48% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BRKR to the average of the S&P500 Index (34.45), we can say BRKR is valued slightly cheaper.
Industry RankSector Rank
PE 24.6
Fwd PE 21.31
BRKR Price Earnings VS Forward Price EarningsBRKR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BRKR is valued cheaply inside the industry as 86.21% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.04
BRKR Per share dataBRKR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)2.75
EPS Next 2Y-2.13%
EPS Next 3Y4.74%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.46%, BRKR is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.49, BRKR pays a better dividend. On top of this BRKR pays more dividend than 89.66% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, BRKR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.46%

5.2 History

The dividend of BRKR has a limited annual growth rate of 4.81%.
BRKR has been paying a dividend for at least 10 years, so it has a reliable track record.
As BRKR did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)4.81%
Div Incr Years0
Div Non Decr Years8
BRKR Yearly Dividends per shareBRKR Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

The earnings of BRKR are negative and hence is the payout ratio. BRKR will probably not be able to sustain this dividend level.
The dividend of BRKR is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP-96.62%
EPS Next 2Y-2.13%
EPS Next 3Y4.74%
BRKR Yearly Income VS Free CF VS DividendBRKR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

BRUKER CORP

NASDAQ:BRKR (11/25/2025, 11:14:08 AM)

49.205

+1.64 (+3.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-03 2025-11-03/bmo
Earnings (Next)02-11 2026-02-11/amc
Inst Owners84.43%
Inst Owner Change6.36%
Ins Owners26.98%
Ins Owner Change0.17%
Market Cap7.47B
Revenue(TTM)3.44B
Net Income(TTM)-23.70M
Analysts76.19
Price Target47.46 (-3.55%)
Short Float %13.43%
Short Ratio4.09
Dividend
Industry RankSector Rank
Dividend Yield 0.46%
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP-96.62%
Div Incr Years0
Div Non Decr Years8
Ex-Date12-08 2025-12-08 (0.05)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.84%
Min EPS beat(2)-26.01%
Max EPS beat(2)31.69%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-26.01%
Max EPS beat(4)31.69%
EPS beat(8)5
Avg EPS beat(8)4.64%
EPS beat(12)9
Avg EPS beat(12)5.65%
EPS beat(16)11
Avg EPS beat(16)6.13%
Revenue beat(2)0
Avg Revenue beat(2)-2.12%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)-0.6%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)6
Avg Revenue beat(12)0.67%
Revenue beat(16)9
Avg Revenue beat(16)0.72%
PT rev (1m)3.71%
PT rev (3m)3.33%
EPS NQ rev (1m)-23.81%
EPS NQ rev (3m)-25.12%
EPS NY rev (1m)-0.24%
EPS NY rev (3m)-2.81%
Revenue NQ rev (1m)-3.51%
Revenue NQ rev (3m)-3.7%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.34%
Valuation
Industry RankSector Rank
PE 24.6
Fwd PE 21.31
P/S 2.17
P/FCF N/A
P/OCF 79.17
P/B 3.07
P/tB N/A
EV/EBITDA 17.04
EPS(TTM)2
EY4.06%
EPS(NY)2.31
Fwd EY4.69%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.62
OCFY1.26%
SpS22.67
BVpS16.03
TBVpS-0.24
PEG (NY)N/A
PEG (5Y)2.75
Graham Number26.86
Profitability
Industry RankSector Rank
ROA -0.37%
ROE -0.97%
ROCE 5.98%
ROIC 4.01%
ROICexc 4.25%
ROICexgc 8.62%
OM 8.99%
PM (TTM) N/A
GM 48%
FCFM N/A
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF N/A
Debt/EBITDA 3.79
Cap/Depr 48.77%
Cap/Sales 3.05%
Interest Coverage 250
Cash Conversion 17.99%
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 0.89
Altman-Z 2.49
F-Score5
WACC9.33%
ROIC/WACC0.43
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
EPS Next Y-17.24%
EPS Next 2Y-2.13%
EPS Next 3Y4.74%
EPS Next 5Y4.89%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
Revenue Next Year2.6%
Revenue Next 2Y1.97%
Revenue Next 3Y3.23%
Revenue Next 5Y2.65%
EBIT growth 1Y-16.55%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year15.58%
EBIT Next 3Y13.09%
EBIT Next 5Y8.69%
FCF growth 1Y-105.14%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y-70.17%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%

BRUKER CORP / BRKR FAQ

Can you provide the ChartMill fundamental rating for BRUKER CORP?

ChartMill assigns a fundamental rating of 4 / 10 to BRKR.


What is the valuation status of BRUKER CORP (BRKR) stock?

ChartMill assigns a valuation rating of 3 / 10 to BRUKER CORP (BRKR). This can be considered as Overvalued.


Can you provide the profitability details for BRUKER CORP?

BRUKER CORP (BRKR) has a profitability rating of 5 / 10.


What is the expected EPS growth for BRUKER CORP (BRKR) stock?

The Earnings per Share (EPS) of BRUKER CORP (BRKR) is expected to decline by -17.24% in the next year.


Is the dividend of BRUKER CORP sustainable?

The dividend rating of BRUKER CORP (BRKR) is 4 / 10 and the dividend payout ratio is -96.62%.